Tuesday, 28 December 2010

Mécillinam




Mécillinam may be available in the countries listed below.


Ingredient matches for Mécillinam



Mecillinam

Mécillinam (DCF) is also known as Mecillinam (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 27 December 2010

Salbu Easyhaler




Salbu Easyhaler may be available in the countries listed below.


Ingredient matches for Salbu Easyhaler



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salbu Easyhaler in the following countries:


  • Germany

International Drug Name Search

Saturday, 25 December 2010

Lorazepam-Eurogenerics




Lorazepam-Eurogenerics may be available in the countries listed below.


Ingredient matches for Lorazepam-Eurogenerics



Lorazepam

Lorazepam is reported as an ingredient of Lorazepam-Eurogenerics in the following countries:


  • Luxembourg

International Drug Name Search

Acido Fusidico




Acido Fusidico may be available in the countries listed below.


Ingredient matches for Acido Fusidico



Fusidic Acid

Acido Fusidico (DCIT) is known as Fusidic Acid in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 24 December 2010

Tonsillitis/Pharyngitis Medications


Drugs associated with Tonsillitis/Pharyngitis

The following drugs and medications are in some way related to, or used in the treatment of Tonsillitis/Pharyngitis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Tonsillitis/Pharyngitis





Drug List:

Rowasa rectal


Generic Name: mesalamine (rectal) (me SAL a meen)

Brand Names: Canasa, Canasa Pac, Rowasa


What is Rowasa (mesalamine (rectal))?

Mesalamine affects a substance in the body that causes inflammation, tissue damage, and diarrhea.


Mesalamine rectal is used to treat ulcerative colitis, proctitis, and proctosigmoiditis. Mesalamine is also used to prevent the symptoms of ulcerative colitis from recurring.


Mesalamine rectal may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Rowasa (mesalamine (rectal))?


Do not take mesalamine rectal by mouth. It is for use only in your rectum. Tell your doctor if you have any type of kidney or liver disease, or if you are allergic to aspirin. You may not be able to use mesalamine, or you may need a dosage adjustment or special tests during treatment.

This medication comes with patient instructions for using either the rectal suppository or the rectal enema. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Try to empty your bowel and bladder just before using the mesalamine suppository or enema. Try to use the medicine at a time when you can lie down afterward and hold the medicine in. Avoid using the bathroom during this time. It may be best to use this medicine at bedtime.


Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


Shake the rectal enema liquid well just before each use.

The rectal enema liquid may darken in color after it has been removed from the foil pouch. This should not affect the medicine. However, throw away any enema liquid that has turned dark brown.


Stop using mesalamine and call your doctor at once if you have severe stomach pain, cramping, fever, headache, and bloody diarrhea.

Avoid getting the rectal suppositories or enema liquid on clothing, flooring, painted surfaces, vinyl, marble, granite, and other surfaces. Mesalamine rectal products may stain surfaces.


What should I discuss with my health care provider before taking Rowasa (mesalamine (rectal))?


Tell your doctor if you have any type of kidney or liver disease, or if you are allergic to aspirin. You may not be able to use mesalamine, or you may need a dosage adjustment or special tests during treatment. FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Mesalamine rectal can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use Rowasa (mesalamine (rectal))?


Use this medication exactly as it was prescribed for you. Do not use the medication in larger or smaller amounts, or use it for longer than recommended by your doctor.


Mesalamine rectal comes with patient instructions for using either the rectal suppository or the rectal enema. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Do not take mesalamine rectal by mouth. It is for use only in your rectum.

Try to empty your bowel and bladder just before using the mesalamine suppository or enema. It may be best to use this medicine at bedtime.


Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


For best results from the suppository, lie down after inserting it and hold in the suppository for one to three hours. The suppository will melt quickly once inserted and you should feel little or no discomfort while holding it in. Avoid using the bathroom during this time.


Shake the rectal enema liquid well just before each use.

For best results from the enema, stay lying down for at least 30 minutes after using the enema to allow the liquid to distribute throughout your intestines. Try to hold in the enema all night if possible. Avoid using the bathroom during this time.


The rectal enema liquid may darken in color after it has been removed from the foil pouch. This should not affect the medicine. However, throw away any enema liquid that has turned dark brown.


Store the rectal enema at room temperature away from moisture and heat. Store the rectal suppositories at cool room temperature away from moisture and heat. Do not refrigerate or freeze them.

What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and wait until your next regularly scheduled dose. Try to use the medicine at a time when you can lie down afterward and hold the medicine in. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine. An overdose of mesalamine rectal is not expected to produce life-threatening symptoms.

What should I avoid while taking Rowasa (mesalamine (rectal))?


Avoid getting the rectal suppositories or enema liquid on clothing, flooring, painted surfaces, vinyl, marble, granite, and other surfaces. Mesalamine rectal products may stain surfaces.


Rowasa (mesalamine (rectal)) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using mesalamine rectal and call your doctor at once if you have severe stomach pain, cramping, fever, headache, and bloody diarrhea.

Less serious side effects may include:



  • mild nausea, vomiting, stomach cramps, diarrhea, gas;




  • fever, sore throat, or other flu symptoms;




  • rectal pain, constipation;




  • headache or dizziness;




  • tired feeling; or




  • skin rash.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Rowasa (mesalamine (rectal))?


There may be other drugs that can interact with mesalamine rectal. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Rowasa resources


  • Rowasa Side Effects (in more detail)
  • Rowasa Use in Pregnancy & Breastfeeding
  • Rowasa Drug Interactions
  • Rowasa Support Group
  • 5 Reviews for Rowasa - Add your own review/rating


Compare Rowasa with other medications


  • Crohn's Disease
  • Inflammatory Bowel Disease
  • Ulcerative Colitis
  • Ulcerative Colitis, Active
  • Ulcerative Proctitis


Where can I get more information?


  • Your pharmacist can provide more information about mesalamine rectal.

See also: Rowasa side effects (in more detail)


Thursday, 23 December 2010

Nevralgin




Nevralgin may be available in the countries listed below.


Ingredient matches for Nevralgin



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Nevralgin in the following countries:


  • Romania

International Drug Name Search

Wednesday, 22 December 2010

Telebrix Meglumine




Telebrix Meglumine may be available in the countries listed below.


Ingredient matches for Telebrix Meglumine



Ioxitalamic Acid

Ioxitalamic Acid meglumine (a derivative of Ioxitalamic Acid) is reported as an ingredient of Telebrix Meglumine in the following countries:


  • Czech Republic

  • Luxembourg

International Drug Name Search

Monday, 20 December 2010

Mizollen




Mizollen may be available in the countries listed below.


UK matches:

  • Mizollen 10 mg modified- release tablets (SPC)

Ingredient matches for Mizollen



Mizolastine

Mizolastine is reported as an ingredient of Mizollen in the following countries:


  • Belgium

  • France

  • Germany

  • Greece

  • Israel

  • Italy

  • Luxembourg

  • Netherlands

  • Poland

  • Portugal

  • South Africa

  • Sweden

  • Switzerland

  • Taiwan

  • Tunisia

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 19 December 2010

Epoetin Delta




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B03XA01

CAS registry number (Chemical Abstracts Service)

0261356-80-3

Chemical Formula

C809-H1301-N229-O240-S5

Molecular Weight

18236

Therapeutic Categories

Antianemic agent

Hematopoietic growth factor

Chemical Name

1-165-erythropoietin (human HMR4396), glycoform delta (WHO)

Foreign Names

  • Epoetinum Delta (Latin)
  • Epoetin Delta (German)
  • Epoétine Delta (French)
  • Epoetina Delta (Spanish)

Generic Names

  • Epoetin Delta (OS: USAN)
  • GA-EPO (IS: Aventis)
  • HMR-4396 (IS)
  • MDL-104396 (IS)

Brand Names

  • Dynepo
    Shire, Greece; Shire, Slovakia

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 14 December 2010

Travelmin




Travelmin may be available in the countries listed below.


Ingredient matches for Travelmin



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Travelmin in the following countries:


  • Argentina

Diphenhydramine

Diphenhydramine is reported as an ingredient of Travelmin in the following countries:


  • Japan

Diprophylline

Diprophylline is reported as an ingredient of Travelmin in the following countries:


  • Japan

International Drug Name Search

Monday, 13 December 2010

Propranolol AccordHealthcare




Propranolol AccordHealthcare may be available in the countries listed below.


Ingredient matches for Propranolol AccordHealthcare



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol AccordHealthcare in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 5 December 2010

Hesmin




Hesmin may be available in the countries listed below.


Ingredient matches for Hesmin



Diosmin

Diosmin is reported as an ingredient of Hesmin in the following countries:


  • Indonesia

Hesperidin

Hesperidin is reported as an ingredient of Hesmin in the following countries:


  • Indonesia

International Drug Name Search

Thursday, 2 December 2010

Riohard




Riohard may be available in the countries listed below.


Ingredient matches for Riohard



Nisoldipine

Nisoldipine is reported as an ingredient of Riohard in the following countries:


  • Japan

International Drug Name Search

Saturday, 20 November 2010

Dermesone




Dermesone may be available in the countries listed below.


Ingredient matches for Dermesone



Betamethasone

Betamethasone is reported as an ingredient of Dermesone in the following countries:


  • Bahrain

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Nigeria

  • Qatar

  • Saudi Arabia

  • Somalia

  • Sudan

  • United Arab Emirates

  • Yemen

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Dermesone in the following countries:


  • Oman

International Drug Name Search

Friday, 5 November 2010

Doxepin Sunve




Doxepin Sunve may be available in the countries listed below.


Ingredient matches for Doxepin Sunve



Doxepin

Doxepin hydrochloride (a derivative of Doxepin) is reported as an ingredient of Doxepin Sunve in the following countries:


  • China

International Drug Name Search

Wednesday, 3 November 2010

Dilzacard




Dilzacard may be available in the countries listed below.


Ingredient matches for Dilzacard



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Dilzacard in the following countries:


  • Bahrain

  • Iraq

  • Lebanon

  • Libya

  • Nigeria

  • Oman

  • Saudi Arabia

  • Somalia

  • Sudan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Thursday, 28 October 2010

Betabloquin




Betabloquin may be available in the countries listed below.


Ingredient matches for Betabloquin



Atenolol

Atenolol is reported as an ingredient of Betabloquin in the following countries:


  • Dominican Republic

International Drug Name Search

Wednesday, 27 October 2010

Helvemigran




Helvemigran may be available in the countries listed below.


Ingredient matches for Helvemigran



Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Helvemigran in the following countries:


  • Switzerland

International Drug Name Search

Monday, 25 October 2010

Carbocromen




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01DX05

CAS registry number (Chemical Abstracts Service)

0000804-10-4

Chemical Formula

C20-H27-N-O5

Molecular Weight

361

Therapeutic Category

Coronary vasodilator

Chemical Name

Acetic acid, [[3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-1-benzopyran-7-yl]oxy]-, ethyl ester

Foreign Names

  • Carbocromenum (Latin)
  • Carbocromen (German)
  • Carbocromène (French)
  • Carbocromeno (Spanish)

Generic Names

  • Carbocromene (OS: DCIT)
  • Carbocromène (OS: DCF)
  • Carbocromen Hydrochloride (OS: JAN)
  • Chromonar Hydrochloride (OS: USAN)
  • A 27053 (IS)
  • AG-3 (IS)
  • Cassella 4489 (IS)
  • NSC 110430 (IS)

Brand Name

  • Intensain
    Therabel, Luxembourg

International Drug Name Search

Glossary

DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 24 October 2010

Clindox




Clindox may be available in the countries listed below.


Ingredient matches for Clindox



Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Clindox in the following countries:


  • Peru

  • Venezuela

International Drug Name Search

Friday, 22 October 2010

Locoïd




Locoïd may be available in the countries listed below.


Ingredient matches for Locoïd



Hydrocortisone

Hydrocortisone 17α-butyrate (a derivative of Hydrocortisone) is reported as an ingredient of Locoïd in the following countries:


  • France

International Drug Name Search

Wednesday, 20 October 2010

Anadent




Anadent may be available in the countries listed below.


Ingredient matches for Anadent



Benzocaine

Benzocaine is reported as an ingredient of Anadent in the following countries:


  • Israel

International Drug Name Search

Saturday, 16 October 2010

Temoret




Temoret may be available in the countries listed below.


Ingredient matches for Temoret



Atenolol

Atenolol is reported as an ingredient of Temoret in the following countries:


  • Ethiopia

International Drug Name Search

Vancomycin DBL




Vancomycin DBL may be available in the countries listed below.


Ingredient matches for Vancomycin DBL



Vancomycin

Vancomycin hydrochloride (a derivative of Vancomycin) is reported as an ingredient of Vancomycin DBL in the following countries:


  • Bangladesh

  • Turkey

International Drug Name Search

Thursday, 7 October 2010

Bonalfa High




Bonalfa High may be available in the countries listed below.


Ingredient matches for Bonalfa High



Tacalcitol

Tacalcitol is reported as an ingredient of Bonalfa High in the following countries:


  • Japan

International Drug Name Search

Monday, 27 September 2010

Ceflong




Ceflong may be available in the countries listed below.


Ingredient matches for Ceflong



Cefalexin

Cefalexin is reported as an ingredient of Ceflong in the following countries:


  • Japan

International Drug Name Search

Sunday, 19 September 2010

Doxepin beta




Doxepin beta may be available in the countries listed below.


Ingredient matches for Doxepin beta



Doxepin

Doxepin hydrochloride (a derivative of Doxepin) is reported as an ingredient of Doxepin beta in the following countries:


  • Germany

International Drug Name Search

Thursday, 16 September 2010

Zerobac




Zerobac may be available in the countries listed below.


Ingredient matches for Zerobac



Erythromycin

Erythromycin is reported as an ingredient of Zerobac in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, 14 September 2010

TRH Prem




TRH Prem may be available in the countries listed below.


Ingredient matches for TRH Prem



Protirelin

Protirelin is reported as an ingredient of TRH Prem in the following countries:


  • Spain

International Drug Name Search

Monday, 13 September 2010

Cinal




Cinal may be available in the countries listed below.


Ingredient matches for Cinal



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Cinal in the following countries:


  • Japan

Calcium Pantothenate

Calcium Pantothenate is reported as an ingredient of Cinal in the following countries:


  • Japan

International Drug Name Search

Tuesday, 7 September 2010

Enalapril Sandoz




Enalapril-Sandoz may be available in the countries listed below.


Ingredient matches for Enalapril-Sandoz



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril-Sandoz in the following countries:


  • Austria

  • Belgium

  • France

  • Germany

  • Italy

  • Lithuania

  • Luxembourg

  • Portugal

  • Spain

  • Sweden

International Drug Name Search

Thursday, 26 August 2010

Doxo Ebewe




Doxo Ebewe may be available in the countries listed below.


Ingredient matches for Doxo Ebewe



Doxorubicin

Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Doxo Ebewe in the following countries:


  • Germany

International Drug Name Search

Monday, 23 August 2010

Piroctone




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0050650-76-5

Chemical Formula

C14-H23-N-O2

Molecular Weight

237

Therapeutic Category

Dermatological agent: Antiseborrheic

Chemical Name

2(1H)-Pyridinone, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-

Foreign Names

  • Piroctonum (Latin)
  • Pirocton (German)
  • Piroctone (French)
  • Piroctona (Spanish)

Generic Names

  • Piroctone (OS: USAN)
  • Piroctone Olamine (OS: USAN)
  • Piroctone ethanolamine (IS)

Brand Names

  • Betapirox
    Roemmers, Peru; Roemmers, Venezuela

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 20 August 2010

Carboplatine G Gam




Carboplatine G Gam may be available in the countries listed below.


Ingredient matches for Carboplatine G Gam



Carboplatin

Carboplatin is reported as an ingredient of Carboplatine G Gam in the following countries:


  • France

International Drug Name Search

Sunday, 15 August 2010

Pankreatin




Pankreatin may be available in the countries listed below.


Ingredient matches for Pankreatin



Pancreatin

Pancreatin is reported as an ingredient of Pankreatin in the following countries:


  • Georgia

  • Serbia

  • Slovenia

International Drug Name Search

Saturday, 14 August 2010

Gen-Mirtazapine




Gen-Mirtazapine may be available in the countries listed below.


Ingredient matches for Gen-Mirtazapine



Mirtazapine

Mirtazapine is reported as an ingredient of Gen-Mirtazapine in the following countries:


  • Canada

International Drug Name Search

Wednesday, 11 August 2010

Gentamicin-Chinoin




Gentamicin-Chinoin may be available in the countries listed below.


Ingredient matches for Gentamicin-Chinoin



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamicin-Chinoin in the following countries:


  • Hungary

International Drug Name Search

Monday, 9 August 2010

L-Citrulline




L-Citrulline may be available in the countries listed below.


Ingredient matches for L-Citrulline



Citrulline, L-

L-Citrulline (DCF) is also known as Citrulline, L- (DCF)

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 4 August 2010

Coreg




In the US, Coreg (carvedilol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat Angina, Atrial Fibrillation, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

  • Coreg

  • Coreg CR Extended-Release Capsules

  • Coreg CR

Ingredient matches for Coreg



Carvedilol

Carvedilol is reported as an ingredient of Coreg in the following countries:


  • Brazil

  • United States

International Drug Name Search

Monday, 2 August 2010

Rossitrol




Rossitrol may be available in the countries listed below.


Ingredient matches for Rossitrol



Roxithromycin

Roxithromycin is reported as an ingredient of Rossitrol in the following countries:


  • Italy

International Drug Name Search

Sunday, 1 August 2010

Dépamide




Dépamide may be available in the countries listed below.


Ingredient matches for Dépamide



Valpromide

Valpromide is reported as an ingredient of Dépamide in the following countries:


  • France

  • Tunisia

International Drug Name Search

Biperiden Hydrochloride




Biperiden Hydrochloride may be available in the countries listed below.


Ingredient matches for Biperiden Hydrochloride



Biperiden

Biperiden Hydrochloride (BANM, JAN, USAN) is known as Biperiden in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 31 July 2010

Teveten


Teveten is a brand name of eprosartan, approved by the FDA in the following formulation(s):


TEVETEN (eprosartan mesylate - tablet; oral)



  • Manufacturer: ABBOTT

    Approval date: December 22, 1997

    Strength(s): EQ 400MG BASE [AB]


  • Manufacturer: ABBOTT

    Approval date: May 27, 1999

    Strength(s): EQ 600MG BASE [RLD][AB]

Has a generic version of Teveten been approved?


A generic version of Teveten has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Teveten and have been approved by the FDA:


eprosartan mesylate tablet; oral



  • Manufacturer: MYLAN PHARMS INC

    Approval date: November 16, 2011

    Strength(s): EQ 400MG BASE [AB], EQ 600MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Teveten. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Angiotensin II receptor blocking compositions
    Patent 5,656,650
    Issued: August 12, 1997
    Inventor(s): Weinstock; Joseph
    Assignee(s): SmithKline Beecham Corp.
    This invention relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier, an angiotensin II receptor antagonist and a second agent selected from a diuretic, a calcium channel blocker, a .beta.-adrenoceptor blocker, a renin inhibitor, or an angiotensin converting enzyme inhibitor and a method of treating hypertension.
    Patent expiration dates:

    • August 12, 2014
      ✓ 
      Patent use: TREATMENT OF HYPERTENSION



See also...

  • Teveten Consumer Information (Wolters Kluwer)
  • Teveten Consumer Information (Cerner Multum)
  • Teveten Advanced Consumer Information (Micromedex)
  • Teveten AHFS DI Monographs (ASHP)
  • Eprosartan Consumer Information (Wolters Kluwer)
  • Eprosartan Consumer Information (Cerner Multum)
  • Eprosartan Advanced Consumer Information (Micromedex)
  • Eprosartan Mesylate AHFS DI Monographs (ASHP)

Wednesday, 28 July 2010

Hippurat-Iod-123 Heider




Hippurat-Iod-123 Heider may be available in the countries listed below.


Ingredient matches for Hippurat-Iod-123 Heider



Sodium

Sodium mixture of several salts (a derivative of Sodium) is reported as an ingredient of Hippurat-Iod-123 Heider in the following countries:


  • Switzerland

International Drug Name Search

Sunday, 25 July 2010

Colmax




Colmax may be available in the countries listed below.


Ingredient matches for Colmax



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Colmax in the following countries:


  • Vietnam

Clonixin

Clonixin lysine salt (a derivative of Clonixin) is reported as an ingredient of Colmax in the following countries:


  • Chile

Paracetamol

Paracetamol is reported as an ingredient of Colmax in the following countries:


  • Vietnam

International Drug Name Search

Wednesday, 21 July 2010

Vitamin B Komplex Sanum




Vitamin B Komplex Sanum may be available in the countries listed below.


Ingredient matches for Vitamin B Komplex Sanum



Thiamine

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Vitamin B Komplex Sanum in the following countries:


  • Germany

International Drug Name Search

Wednesday, 14 July 2010

Termalgin Codeina




Termalgin Codeina may be available in the countries listed below.


Ingredient matches for Termalgin Codeina



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Termalgin Codeina in the following countries:


  • Spain

Paracetamol

Paracetamol is reported as an ingredient of Termalgin Codeina in the following countries:


  • Spain

International Drug Name Search

Friday, 9 July 2010

Dipivefrine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01EA02

CAS registry number (Chemical Abstracts Service)

0052365-63-6

Chemical Formula

C19-H29-N-05

Molecular Weight

285

Therapeutic Categories

Mydriatic agent

Sympathomimetic agent

Chemical Name

Propanoic acid, 2,2-dimethyl-, 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester, (±)-

Foreign Names

  • Dipivefrinum (Latin)
  • Dipivefrin (German)
  • Dipivéfrine (French)
  • Dipivefrina (Spanish)

Generic Names

  • Dipivefrin (OS: USAN)
  • Dipivefrina (OS: DCIT)
  • Dipivefrine (OS: BAN)
  • Dipivéfrine (OS: DCF)
  • Dipivalyl Epinephrine (IS)
  • DPE (IS)
  • Epinephrine dipivalate (IS)
  • K 30081 (IS: KlingePharma)
  • Pro-Epinephrine (IS)
  • Dipivefrin Hydrochloride (OS: JAN)
  • Dipivefrine Hydrochloride (OS: BANM)
  • Dipivefrin hydrochloride (PH: USP 32)
  • Dipivefrine hydrochloride (PH: BP 2010, Ph. Eur. 6)
  • Dipivefrini hydrochloridum (PH: Ph. Eur. 6)

Brand Names

  • AKPro
    Akorn, United States


  • D Epifrin
    Pharm Allergan, Germany


  • Difrin
    Vitamed, Israel


  • Diopine
    Allergan, Spain; Allergan, Netherlands


  • Dipivefrin Hydrochloride
    Bausch & Lomb, United States; Falcon, United States


  • Pivalephrine
    Santen, Japan


  • Progate
    Nippon Tenganyaku KenkyujoNitten, Japan


  • Propine
    Allergan, Belgium; Allergan, Brazil; Allergan, Egypt; Allergan, Finland; Allergan, France; Allergan, United Kingdom; Allergan, Ireland; Allergan, Italy; Allergan, Luxembourg; Allergan, Norway; Allergan, Oman; Allergan, Portugal; Allergan, United States; Allergan PharmaceuticalsIR, Denmark


  • Thilodrin
    Alcon, Greece

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 6 July 2010

Benadryl Allergy Fastmelt Dispersible Tablets


Pronunciation: dye-fen-HYE-dra-meen
Generic Name: Diphenhydramine
Brand Name: Benadryl Allergy Fastmelt


Benadryl Allergy Fastmelt Dispersible Tablets are used for:

Preventing or treating symptoms of hay fever and other upper respiratory allergies or the common cold, such as runny nose, sneezing, itching of the nose and throat, and itchy, watery eyes, and relieving cough. It may also be used for other conditions as determined by your doctor.


Benadryl Allergy Fastmelt Dispersible Tablets are an antihistamine and anticholinergic. It works by blocking the action of histamine, reducing the symptoms of an allergic reaction. It also works in the brain to cause sedation.


Do NOT use Benadryl Allergy Fastmelt Dispersible Tablets if:


  • you are allergic to any ingredient in Benadryl Allergy Fastmelt Dispersible Tablets or other similar medicines

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Benadryl Allergy Fastmelt Dispersible Tablets:


Some medical conditions may interact with Benadryl Allergy Fastmelt Dispersible Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a fast, slow, or irregular heartbeat

  • if you have a history of asthma; chronic obstructive pulmonary disease (COPD); chronic bronchitis; lung problems (eg, emphysema); shortness of breath; sleep apnea; heart blood vessel problems; stroke; seizures; a blockage of your stomach, intestine, or bladder; difficulty urinating; diabetes; ulcers; an enlarged prostate or other prostate problems; glaucoma; heart problems; high blood pressure; porphyria; phenylketonuria; or an overactive thyroid

Some MEDICINES MAY INTERACT with Benadryl Allergy Fastmelt Dispersible Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Sodium oxybate (GHB) because an increase in sleep duration and a decrease in the ability to breathe are likely to occur

  • Monoamine oxidase (MAO) inhibitors (eg, phenelzine) because they may increase the risk of Benadryl Allergy Fastmelt Dispersible Tabletss side effects

This may not be a complete list of all interactions that may occur. Ask your health care provider if Benadryl Allergy Fastmelt Dispersible Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Benadryl Allergy Fastmelt Dispersible Tablets:


Use Benadryl Allergy Fastmelt Dispersible Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Benadryl Allergy Fastmelt Dispersible Tablets by mouth with or without food.

  • Let the tablet dissolve in the mouth before swallowing.

  • Use Benadryl Allergy Fastmelt Dispersible Tablets exactly as directed on the package, unless instructed differently by your doctor. If you are taking Benadryl Allergy Fastmelt Dispersible Tablets without a prescription, follow any warnings and precautions on the label.

  • If you miss a dose of Benadryl Allergy Fastmelt Dispersible Tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Benadryl Allergy Fastmelt Dispersible Tablets.



Important safety information:


  • Benadryl Allergy Fastmelt Dispersible Tablets may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Benadryl Allergy Fastmelt Dispersible Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Benadryl Allergy Fastmelt Dispersible Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Benadryl Allergy Fastmelt Dispersible Tablets may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Do not become overheated in hot weather or while you are being active; heatstroke may occur.

  • Benadryl Allergy Fastmelt Dispersible Tablets may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Benadryl Allergy Fastmelt Dispersible Tablets for a few days before the tests.

  • Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.

  • Benadryl Allergy Fastmelt Dispersible Tablets may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Benadryl Allergy Fastmelt Dispersible Tablets. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Benadryl Allergy Fastmelt Dispersible Tablets has diphenhydramine in it. Before you start any new medicine, check the label to see if it has diphenhydramine in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Do not use Benadryl Allergy Fastmelt Dispersible Tablets for a cough with a lot of mucous. Do not use it for a long-term cough (eg, caused by asthma, emphysema, smoking). However, you may use it for these conditions if your doctor tells you to.

  • If your symptoms persist for more than 1 week or if you develop a fever, contact your health care provider.

  • Use Benadryl Allergy Fastmelt Dispersible Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially dizziness, sedation, and lightheadedness upon standing.

  • Different brands of Benadryl Allergy Fastmelt Dispersible Tablets may have different dosing instructions for CHILDREN. Follow the dosing instructions on the package labeling. If your doctor has given you instructions, follow those. If you are unsure of the dose to give a child, check with your doctor or pharmacist.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Benadryl Allergy Fastmelt Dispersible Tablets while you are pregnant. Benadryl Allergy Fastmelt Dispersible Tablets are found in breast milk. If you are or will be breast-feeding while you use Benadryl Allergy Fastmelt Dispersible Tablets, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Benadryl Allergy Fastmelt Dispersible Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; drowsiness; dry mouth, throat, and nose; excitability; thickening of mucus in nose or throat.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); convulsions; fast heartbeat or pounding in the chest; decreased alertness; hallucinations; tremor; wheezing.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Benadryl Allergy Fastmelt side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; excitement; hallucinations; loss of consciousness; muscle twitching; seizures; tremor; weakness.


Proper storage of Benadryl Allergy Fastmelt Dispersible Tablets:

Store Benadryl Allergy Fastmelt Dispersible Tablets at room temperature, between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Benadryl Allergy Fastmelt Dispersible Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Benadryl Allergy Fastmelt Dispersible Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Benadryl Allergy Fastmelt Dispersible Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Benadryl Allergy Fastmelt Dispersible Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Benadryl Allergy Fastmelt resources


  • Benadryl Allergy Fastmelt Side Effects (in more detail)
  • Benadryl Allergy Fastmelt Use in Pregnancy & Breastfeeding
  • Drug Images
  • Benadryl Allergy Fastmelt Drug Interactions
  • Benadryl Allergy Fastmelt Support Group
  • 18 Reviews for Benadryl Allergy Fastmelt - Add your own review/rating


Compare Benadryl Allergy Fastmelt with other medications


  • Allergic Reactions
  • Cold Symptoms
  • Cough
  • Extrapyramidal Reaction
  • Hay Fever
  • Insomnia
  • Motion Sickness
  • Nausea/Vomiting
  • Pruritus
  • Urticaria

Saturday, 3 July 2010

Omeprazol Hexal




Omeprazol Hexal may be available in the countries listed below.


Ingredient matches for Omeprazol Hexal



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Hexal in the following countries:


  • Hungary

International Drug Name Search

Thursday, 1 July 2010

Oxymétholone




Oxymétholone may be available in the countries listed below.


Ingredient matches for Oxymétholone



Oxymetholone

Oxymétholone (DCF) is known as Oxymetholone in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 24 June 2010

Accutane




In the US, Accutane (isotretinoin systemic) is a member of the following drug classes: miscellaneous antineoplastics, miscellaneous uncategorized agents and is used to treat Acne, Acute Nonlymphocytic Leukemia, Granuloma Annulare, Melanoma - Metastatic and Rosacea.

US matches:

  • Accutane

Ingredient matches for Accutane



Isotretinoin

Isotretinoin is reported as an ingredient of Accutane in the following countries:


  • Canada

  • United States

International Drug Name Search

Wednesday, 23 June 2010

Metoclopramide Hydrochloride




UK matches:

  • Metoclopramide Hydrochloride Oral Solution
  • Metoclopramide Hydrochloride Oral Solution (Rosemont Pharmaceuticals Ltd) (SPC)

Ingredient matches for Metoclopramide Hydrochloride



Metoclopramide

Metoclopramide Hydrochloride (BANM, JAN, USAN) is known as Metoclopramide in the US.



Losartan

Losartan is reported as an ingredient of Metoclopramide Hydrochloride in the following countries:


  • Bangladesh

Metoprolol

Metoprolol succinate (a derivative of Metoprolol) is reported as an ingredient of Metoclopramide Hydrochloride in the following countries:


  • United States

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 17 June 2010

Docacetyl




Docacetyl may be available in the countries listed below.


Ingredient matches for Docacetyl



Acetylcysteine

Acetylcysteine is reported as an ingredient of Docacetyl in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Wednesday, 16 June 2010

Cloxacilina




Cloxacilina may be available in the countries listed below.


Ingredient matches for Cloxacilina



Cloxacillin

Cloxacillin is reported as an ingredient of Cloxacilina in the following countries:


  • Chile

  • Peru

Cloxacillin sodium salt (a derivative of Cloxacillin) is reported as an ingredient of Cloxacilina in the following countries:


  • Chile

International Drug Name Search

Wednesday, 9 June 2010

Kuritch




Kuritch may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Kuritch



Diethyltoluamide

Diethyltoluamide is reported as an ingredient of Kuritch in the following countries:


  • Australia

International Drug Name Search

Tuesday, 25 May 2010

Dobutan




Dobutan may be available in the countries listed below.


Ingredient matches for Dobutan



Dobutamine

Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Dobutan in the following countries:


  • Greece

International Drug Name Search

Friday, 21 May 2010

Canri




Canri may be available in the countries listed below.


Ingredient matches for Canri



Irinotecan

Irinotecan hydrochloride trihydrate (a derivative of Irinotecan) is reported as an ingredient of Canri in the following countries:


  • Czech Republic

International Drug Name Search

Digoxin Nycomed




Digoxin Nycomed may be available in the countries listed below.


Ingredient matches for Digoxin Nycomed



Digoxin

Digoxin is reported as an ingredient of Digoxin Nycomed in the following countries:


  • Estonia

International Drug Name Search

Sunday, 16 May 2010

Dexa-Rhinospray




Dexa-Rhinospray may be available in the countries listed below.


Ingredient matches for Dexa-Rhinospray



Dexamethasone

Dexamethasone 21-isonicotinate (a derivative of Dexamethasone) is reported as an ingredient of Dexa-Rhinospray in the following countries:


  • Bahrain

  • Belgium

  • Greece

Tramazoline

Tramazoline hydrochloride (a derivative of Tramazoline) is reported as an ingredient of Dexa-Rhinospray in the following countries:


  • Belgium

  • Greece

International Drug Name Search

Saturday, 15 May 2010

Laudamonium




Laudamonium may be available in the countries listed below.


Ingredient matches for Laudamonium



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Laudamonium in the following countries:


  • Germany

International Drug Name Search

Tuesday, 11 May 2010

Duro-Tuss Decongestant




Duro-Tuss Decongestant may be available in the countries listed below.


Ingredient matches for Duro-Tuss Decongestant



Pholcodine

Pholcodine is reported as an ingredient of Duro-Tuss Decongestant in the following countries:


  • Singapore

International Drug Name Search

Friday, 7 May 2010

Pancrease




In the US, Pancrease (pancrelipase systemic) is a member of the drug class digestive enzymes and is used to treat Chronic Pancreatitis, Cystic Fibrosis and Pancreatic Exocrine Dysfunction.

US matches:

  • Pancrease MT Capsules (Enteric-Coated)

  • Pancrease MT 10

  • Pancrease MT 16

  • Pancrease MT 20

  • Pancrease MT 4

UK matches:

  • Pancrease HL Capsules (SPC)

Ingredient matches for Pancrease



Pancreatin

Pancreatin is reported as an ingredient of Pancrease in the following countries:


  • Brazil

  • Ireland

  • Netherlands

  • United Kingdom

Pancrelipase

Pancrelipase is reported as an ingredient of Pancrease in the following countries:


  • Canada

  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Iceland

  • Israel

  • Nicaragua

  • Panama

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Vitamine D3 BON




Vitamine D3 BON may be available in the countries listed below.


Ingredient matches for Vitamine D3 BON



Colecalciferol

Colecalciferol is reported as an ingredient of Vitamine D3 BON in the following countries:


  • Algeria

  • France

  • Lithuania

  • Sri Lanka

  • Tunisia

  • Vietnam

International Drug Name Search

Thursday, 6 May 2010

Enabran




Enabran may be available in the countries listed below.


Ingredient matches for Enabran



Haloperidol

Haloperidol is reported as an ingredient of Enabran in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 5 May 2010

Doxazosina Neo Acost




Doxazosina Neo Acost may be available in the countries listed below.


Ingredient matches for Doxazosina Neo Acost



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosina Neo Acost in the following countries:


  • Spain

International Drug Name Search

Monday, 3 May 2010

dexchlorpheniramine and pseudoephedrine


Generic Name: dexchlorpheniramine and pseudoephedrine (dex klor fen EER a meen and soo doe e FED rin)

Brand names: AllerDur, Duotan PD, Tanafed DP, SuTan


What is dexchlorpheniramine and pseudoephedrine?

Dexchlorpheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of dexchlorpheniramine and pseudoephedrine is used to treat sneezing, cough, runny or stuffy nose, itchy or watery eyes, hives, skin rash, itching, and other symptoms of allergies and the common cold.


Dexchlorpheniramine and pseudoephedrine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about dexchlorpheniramine and pseudoephedrine?


Always ask a doctor before giving a cold or allergy medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Do not use any other over-the-counter cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine or decongestant. Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body. Dexchlorpheniramine and pseudoephedrine can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

What should I discuss with my healthcare provider before taking dexchlorpheniramine and pseudoephedrine?


Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body.

Before taking this medication, tell your doctor if you are allergic to dexchlorpheniramine, or pseudoephedrine, or if you have:


  • kidney disease;


  • diabetes;




  • glaucoma;




  • heart disease or high blood pressure;




  • diabetes;




  • a thyroid disorder;




  • an enlarged prostate; or




  • problems with urination.



If you have any of these conditions, you may not be able to use dexchlorpheniramine and pseudoephedrine, or you may need a dosage adjustment or special tests during treatment.


This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Dexchlorpheniramine and pseudoephedrine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Artificially-sweetened liquid forms of cold medicine may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.


How should I take dexchlorpheniramine and pseudoephedrine?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts, or use it for longer than recommended. Cold medicine is usually taken only for a short time until your symptoms clear up.


Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

Measure the liquid form of this medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash.

If you need to have any type of surgery, tell the surgeon ahead of time if you have taken a cold medicine within the past few days.


This medication can cause you to have unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.


Store the medication at room temperature away from moisture and heat.

See also: Dexchlorpheniramine and pseudoephedrine dosage (in more detail)

What happens if I miss a dose?


Since cold or allergy medicine is usually taken only as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Symptoms of an overdose may include feeling restless or nervous, nausea, vomiting, stomach pain, dizziness, drowsiness, dry mouth, warmth or tingly feeling, or seizure (convulsions).


What should I avoid while taking dexchlorpheniramine and pseudoephedrine?


This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

Avoid using other medicines that make you sleepy (such as sleeping pills, pain medication, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by dexchlorpheniramine and pseudoephedrine.


Avoid taking diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice. Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Do not use any other over-the-counter cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine or decongestant.

Dexchlorpheniramine and pseudoephedrine side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

  • fast, pounding, or uneven heartbeat;




  • confusion, hallucinations, unusual thoughts or behavior;




  • severe dizziness, anxiety, restless feeling, or nervousness;




  • increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure);




  • confusion, hallucinations, unusual thoughts or behavior;




  • easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms; or




  • urinating less than usual or not at all.



Keep taking the medication and talk to your doctor if you have any of these less serious side effects:



  • blurred vision;




  • dry mouth;




  • nausea, stomach pain, constipation;




  • mild loss of appetite, stomach upset;




  • warmth, tingling, or redness under your skin;




  • sleep problems (insomnia);




  • restless or excitability (especially in children);




  • skin rash or itching;




  • dizziness, drowsiness;




  • problems with memory or concentration; or




  • ringing in your ears.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.


Dexchlorpheniramine and pseudoephedrine Dosing Information


Usual Adult Dose for Nasal Congestion:

Dexchlorpheniramine-pseudoephedrine 3 mg-50 mg/5 mL oral suspension, extended release:
15 mL orally every 12 hours not to exceed 30 mL daily.

Usual Pediatric Dose for Nasal Congestion:

Dexchlorpheniramine-pseudoephedrine 3 mg-50 mg/5 mL oral suspension, extended release:
2 to 5 years: 2.5 to 5 mL orally every 12 hours not to exceed 10 mL daily.
6 to 11 years: 5 to 7.5 mL orally every 12 hours not to exceed 15 mL daily.
12 years or older: 15 mL orally every 12 hours not to exceed 30 mL daily.


What other drugs will affect dexchlorpheniramine and pseudoephedrine?


Before taking this medication, tell your doctor if you are using any of the following drugs:



  • medicines to treat high blood pressure;




  • a diuretic (water pill);




  • medication to treat irritable bowel syndrome;




  • bladder or urinary medications such as oxybutynin (Ditropan, Oxytrol) or tolterodine (Detrol);




  • aspirin or salicylates (such as Disalcid, Doan's Pills, Dolobid, Salflex, Tricosal, and others);




  • a beta-blocker such as atenolol (Tenormin), carteolol (Cartrol), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal), sotalol (Betapace), timolol (Blocadren), and others; or




  • antidepressants such as amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Janimine, Tofranil), and others.



If you are using any of these drugs, you may not be able to use dexchlorpheniramine and pseudoephedrine, or you may need dosage adjustments or special tests during treatment.


There may be other drugs not listed that can affect dexchlorpheniramine and pseudoephedrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More dexchlorpheniramine and pseudoephedrine resources


  • Dexchlorpheniramine and pseudoephedrine Side Effects (in more detail)
  • Dexchlorpheniramine and pseudoephedrine Dosage
  • Dexchlorpheniramine and pseudoephedrine Use in Pregnancy & Breastfeeding
  • Dexchlorpheniramine and pseudoephedrine Drug Interactions
  • Dexchlorpheniramine and pseudoephedrine Support Group
  • 0 Reviews for Dexchlorpheniramine and pseudoephedrine - Add your own review/rating


Compare dexchlorpheniramine and pseudoephedrine with other medications


  • Nasal Congestion


Where can I get more information?


  • Your pharmacist has information about dexchlorpheniramine and pseudoephedrine written for health professionals that you may read.

See also: dexchlorpheniramine and pseudoephedrine side effects (in more detail)


Sunday, 2 May 2010

Doc Mebenda




Doc Mebenda may be available in the countries listed below.


Ingredient matches for Doc Mebenda



Mebendazole

Mebendazole is reported as an ingredient of Doc Mebenda in the following countries:


  • Luxembourg

International Drug Name Search

Saturday, 1 May 2010

Selegilina




Selegilina may be available in the countries listed below.


Ingredient matches for Selegilina



Selegiline

Selegilina (DCIT) is known as Selegiline in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 23 April 2010

Zyclara




In the US, Zyclara (imiquimod topical) is a member of the drug class topical anti-infectives and is used to treat Actinic Keratosis and Condylomata Acuminata.

US matches:

  • Zyclara

  • Zyclara Cream

  • Zyclara Topical

Ingredient matches for Zyclara



Imiquimod

Imiquimod is reported as an ingredient of Zyclara in the following countries:


  • United States

International Drug Name Search

Wednesday, 21 April 2010

Microterol




Microterol may be available in the countries listed below.


Ingredient matches for Microterol



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Microterol in the following countries:


  • Argentina

International Drug Name Search

Sunday, 18 April 2010

Silicur




Silicur may be available in the countries listed below.


Ingredient matches for Silicur



Silibinin

Silibinin is reported as an ingredient of Silicur in the following countries:


  • Germany

  • Luxembourg

International Drug Name Search